Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Konkret geht es um den Diabetes-Patienten mit kardiovaskulären Erkrankungen oder Risiken, die Herzinsuffizienz sowie die kardiovaskuläre Primär- und Sekundärprävention. Sind Sie hier schon auf dem neuesten Stand? Unsere Experten beleuchten, wo und warum das bisherige Procedere geändert werden soll und was in der Praxis sinnvoll ist. Holen Sie sich Ihr Update und 2 CME-Punkte beim MMW-Webinar am 24. April von 17.30 bis 19 Uhr. 
Erweiterte Suche
Anmelden
nach oben
International Journal of Colorectal Disease
Erschienen in: International Journal of Colorectal Disease 1/2012

01.01.2012 | Original Article

Association between OCTN1/2 gene polymorphisms (1672C-T, 207G-C) and susceptibility of Crohn's disease: a meta-analysis

verfasst von: Chao Xuan, Bei-Bei Zhang, Tao Yang, Kai-Feng Deng, Ming Li, Rui-Juan Tian

Erschienen in: International Journal of Colorectal Disease | Ausgabe 1/2012

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Although a number of genetic studies have attempted to link organic cation transporter 1/2 (OCTN1/2) polymorphisms to susceptibility of Crohn's disease (CD), the results were often inconsistent. The present study aimed at investigating the associations.

Methods

The PubMed, EBSCO, and BIOSIS databases were searched to identify eligible studies which were published in English before April 2011. The association was assessed by odds ratio (OR) with 95% confidence intervals (CI).

Results

A total of 15 case–control studies, containing 4,489 cases/5,351 controls for OCTN1 and 4,474 cases/5,377 controls for OCTN2 were included. Overall, significant associations were found between OCTN1/2 polymorphisms and susceptibility of Crohn's disease for all genetic models. In the subgroup analyses, significant associations were found in the Caucasian population for OCTN1 (TT vs. CC: OR = 1.425, 95% CI 1.247–1.628; TT vs. CT: OR = 1.299, 95% CI 1.149–1.468; dominant model: OR = 1.344, 95% CI 1.197–1.508; and recessive model: OR = 1.179, 95% CI 1.066–1.305) and for OCTN2 (CC vs. GG: OR = 1.309, 95% CI 1.078–1.588; CC vs. CG: OR = 1.200, 95% CI 1.002–1.438; dominant model (OR = 1.231, 95% CI 1.036–1.462; recessive model: OR = 1.148, 95% CI 1.031–1.279). Significant associations were not found in the East Asian population.

Conclusions

This meta-analysis suggests that OCTN1/2 polymorphisms were associated with susceptibility of CD in the Caucasian population but not in the East Asian population.
Literatur
1.
Latiano A, Palmieri O, Valvano MR et al (2008) Replication of interleukin 23 receptor and autophagy-related 16-like 1 association in adult- and pediatric-onset inflammatory bowel disease in Italy. World J Gastroenterol 14:4643–4651PubMedCrossRef
2.
Bernstein CN (2010) Epidemiologic clues to inflammatory bowel disease. Curr Gastroenterol Rep 12:495–501PubMedCrossRef
3.
Orholm M, Munkholm P, Langholz E et al (1991) Familial occurrence of inflammatory bowel disease. N Engl J Med 324:84–88PubMedCrossRef
4.
Orholm M, Binder V, Sorensen TI et al (2000) Concordance of inflammatory bowel disease among Danish twins: results of a nationwide study. Scand J Gastroenterol 35:1075–1081PubMedCrossRef
5.
Rioux JD, Daly MJ, Silverberg MS et al (2001) Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease. Nat Genet 29:223–228PubMedCrossRef
6.
Duerr RH, Taylor KD, Brant SR et al (2006) A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 314:1461–1463PubMedCrossRef
7.
Libioulle C, Louis E, Hansoul S et al (2007) Novel Crohn disease locus identified by genome-wide association maps to a gene desert on 5p13.1 and modulates expression of PTGER4. PLoS Genet 3:e58PubMedCrossRef
8.
The Wellcome Trust Case Control Consortium (2007) Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447:661–678CrossRef
9.
Raelson JV, Little RD, Ruether A et al (2007) Genome-wide association study for Crohn's disease in the Quebec Founder Population identifies multiple validated disease loci. Proc Natl Acad Sci USA 104:14747–14752PubMedCrossRef
10.
Barrett JC, Hansoul S, Nicolae DL et al (2008) Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet 40:955–962PubMedCrossRef
11.
Peltekova VD, Wintle RF, Rubin LA et al (2004) Functional variants of OCTN cation transporter genes are associated with Crohn disease. Nat Genet 36:471–475PubMedCrossRef
12.
Noble CL, Nimmo ER, Drummond H et al (2005) The contribution of OCTN1/2 variants within the IBD5 locus to disease susceptibility and severity in Crohn's disease. Gastroenterology 129:1854–1864PubMedCrossRef
13.
Thakkinstian A, McEvoy M, Minelli C et al (2005) Systematic review and meta-analysis of the association between {beta}2-adrenoceptor polymorphisms and asthma: a HuGE review. Am J Epidemiol 162:201–211PubMedCrossRef
14.
Sterne JAC, Bradburn MJ, Egger M (2010) Meta-analysis in Stata™. Systematic Reviews 347–369
15.
Wang R, Zhong B, Liu Y et al (2010) Association between alpha-adducin gene polymorphism (Gly460Trp) and genetic predisposition to salt sensitivity: a meta-analysis. J Appl Genet 51:87–94PubMedCrossRef
16.
Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539–1558PubMedCrossRef
17.
Wang B, Wang D, Huang G et al (2010) XRCC1 polymorphisms and risk of colorectal cancer: a meta-analysis. Int J Colorectal Dis 25:313–321PubMedCrossRef
18.
DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177–188PubMedCrossRef
19.
Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22:719–748PubMed
20.
Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50:1088–1101PubMedCrossRef
21.
Palmieri O, Latiano A, Valvano R et al (2006) Variants of OCTN1-2 cation transporter genes are associated with both Crohn's disease and ulcerative colitis. Aliment Pharmacol Ther 23:497–506PubMedCrossRef
22.
Waller S, Tremelling M, Bredin F et al (2006) Evidence for association of OCTN genes and IBD5 with ulcerative colitis. Gut 55:809–814PubMedCrossRef
23.
Torok HP, Glas J, Tonenchi L et al (2005) Polymorphisms in the DLG5 and OCTN cation transporter genes in Crohn's disease. Gut 54:1421–1427PubMedCrossRef
24.
Leung E, Hong J, Fraser AG et al (2006) Polymorphisms in the organic cation transporter genes SLC22A4 and SLC22A5 and Crohn's disease in a New Zealand Caucasian cohort. Immunol Cell Biol 84:233–236PubMedCrossRef
25.
Martinez A, Martin MC, Mendoza JL et al (2006) Association of the organic cation transporter OCTN genes with Crohn's disease in the Spanish population. Eur J Hum Genet 14:222–226PubMedCrossRef
26.
Cucchiara S, Latiano A, Palmieri O et al (2007) Role of CARD15, DLG5 and OCTN genes polymorphisms in children with inflammatory bowel diseases. World J Gastroenterol 13:1221–1229PubMed
27.
Torkvist L, Noble CL, Lordal M et al (2007) Contribution of the IBD5 locus to Crohn's disease in the Swedish population. Scand J Gastroenterol 42:200–206PubMedCrossRef
28.
de Ridder L, Weersma RK, Dijkstra G et al (2007) Genetic susceptibility has a more important role in pediatric-onset Crohn's disease than in adult-onset Crohn's disease. Inflamm Bowel Dis 13:1083–1092PubMedCrossRef
29.
Gaj P, Habior A, Mikula M et al (2008) Lack of evidence for association of primary sclerosing cholangitis and primary biliary cirrhosis with risk alleles for Crohn's disease in Polish patients. BMC Med Genet 9:81PubMedCrossRef
30.
Vermeire S, Pierik M, Hlavaty T et al (2005) Association of organic cation transporter risk haplotype with perianal penetrating Crohn's disease but not with susceptibility to IBD. Gastroenterology 129:1845–1853PubMedCrossRef
31.
Li M, Gao X, Guo CC et al (2008) OCTN and CARD15 gene polymorphism in Chinese patients with inflammatory bowel disease. World J Gastroenterol 14:4923–4927PubMedCrossRef
32.
Gazouli M, Mantzaris G, Archimandritis AJ et al (2005) Single nucleotide polymorphisms of OCTN1, OCTN2, and DLG5 genes in Greek patients with Crohn's disease. World J Gastroenterol 11:7525–7530PubMed
33.
Yamazaki K, Takazoe M, Tanaka T et al (2004) Association analysis of SLC22A4, SLC22A5 and DLG5 in Japanese patients with Crohn disease. J Hum Genet 49:664–668PubMedCrossRef
34.
Tosa M, Negoro K, Kinouchi Y et al (2006) Lack of association between IBD5 and Crohn's disease in Japanese patients demonstrates population-specific differences in inflammatory bowel disease. Scand J Gastroenterol 41:48–53PubMedCrossRef
35.
Lakner L, Csongei V, Sarlos P et al (2009) IGR2096a_1 T and IGR2198a_1 C alleles on IBD5 locus of chromosome 5q31 region confer risk for Crohn's disease in Hungarian patients. Int J Colorectal Dis 24:503–507PubMedCrossRef
36.
Russell RK, Drummond HE, Nimmo ER et al (2006) Analysis of the influence of OCTN1/2 variants within the IBD5 locus on disease susceptibility and growth indices in early onset inflammatory bowel disease. Gut 55:1114–1123PubMedCrossRef
37.
Lappalainen M, Halme L, Turunen U et al (2008) Association of IL23R, TNFRSF1A, and HLA-DRB1*0103 allele variants with inflammatory bowel disease phenotypes in the Finnish population. Inflamm Bowel Dis 14:1118–1124PubMedCrossRef
38.
Babusukumar U, Wang T, McGuire E et al (2006) Contribution of OCTN variants within the IBD5 locus to pediatric onset Crohn's disease. Am J Gastroenterol 101:1354–1361PubMedCrossRef
39.
Newman B, Wintle RF, van Oene M et al (2005) SLC22A4 polymorphisms implicated in rheumatoid arthritis and Crohn's disease are not associated with rheumatoid arthritis in a Canadian Caucasian population. Arthritis Rheum 52:425–429PubMedCrossRef
40.
Hradsky O, Dusatkova P, Lenicek M et al. (2010) Two independent genetic factors responsible for the associations of the IBD5 locus with Crohn's disease in the Czech population. Inflamm Bowel Dis (in press)
41.
Weersma RK, Zhou L, Nolte IM et al (2008) Runt-related transcription factor 3 is associated with ulcerative colitis and shows epistasis with solute carrier family 22, members 4 and 5. Inflamm Bowel Dis 14:1615–1622PubMedCrossRef
42.
Newman B, Gu X, Wintle R et al (2005) A risk haplotype in the Solute Carrier Family 22A4/22A5 gene cluster influences phenotypic expression of Crohn's disease. Gastroenterology 128:260–269PubMedCrossRef
43.
Economou M, Trikalinos TA, Loizou KT et al (2004) Differential effects of NOD2 variants on Crohn's disease risk and phenotype in diverse populations: a metaanalysis. Am J Gastroenterol 99:2393–2404PubMedCrossRef
44.
Craddock N, Hurles ME, Cardin N et al (2010) Genome-wide association study of CNVs in 16,000 cases of eight common diseases and 3,000 shared controls. Nature 464:713–720PubMedCrossRef
45.
Lee JC, Parkes M (2011) Genome-wide association studies and Crohn's disease. Brief Funct Genomics 10:71–76PubMedCrossRef
46.
Franke A, McGovern DP, Barrett JC, Wang K, Radford-Smith GL, Ahmad T et al (2010) Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat Genet 42:1118–1125PubMedCrossRef
47.
Rubin GP, Hungin AP, Kelly PJ et al (2000) Inflammatory bowel disease: epidemiology and management in an English general practice population. Aliment Pharmacol Ther 14:1553–1559PubMedCrossRef
48.
Yao T, Matsui T, Hiwatashi N (2000) Crohn's disease in Japan: diagnostic criteria and epidemiology. Dis Colon Rectum 43:S85–3PubMedCrossRef
49.
Peeters M, Nevens H, Baert F et al (1996) Familial aggregation in Crohn's disease: increased age-adjusted risk and concordance in clinical characteristics. Gastroenterology 111:596–603CrossRef
50.
Weterman IT, Pena AS (1984) Familial incidence of Crohn's disease in The Netherlands and a review of the literature. Gastroenterology 86:449–452PubMed
51.
Yoshida Y, Murata Y (1990) Inflammatory bowel disease in Japan: studies of epidemiology and etiopathogenesis. Med Clin North Am 74:67–90PubMed
52.
Morita N, Toki S, Hirohashi T et al (1995) Incidence and prevalence of inflammatory bowel disease in Japan: nationwide epidemiological survey during the year 1991. J Gastroenterol 30(Suppl 8):1–4PubMed
53.
Cho J (2006) Genetic advances in inflammatory bowel disease. Curr Treat Option Gastroenterol 9:191–200CrossRef
Metadaten
Titel
Association between OCTN1/2 gene polymorphisms (1672C-T, 207G-C) and susceptibility of Crohn's disease: a meta-analysis
verfasst von
Chao Xuan
Bei-Bei Zhang
Tao Yang
Kai-Feng Deng
Ming Li
Rui-Juan Tian
Publikationsdatum
01.01.2012
Verlag
Springer-Verlag
Erschienen in
International Journal of Colorectal Disease / Ausgabe 1/2012
Print ISSN: 0179-1958
Elektronische ISSN: 1432-1262
DOI
https://doi.org/10.1007/s00384-011-1265-x

Weitere Artikel der Ausgabe 1/2012

International Journal of Colorectal Disease 1/2012 Zur Ausgabe

Case Report

Intra-abdominal dilation of artificial bowel sphincter pressure-regulating balloon: a case report

Original Article

Down-regulation of HLA-A mRNA in peripheral blood mononuclear cell of colorectal cancer

Original Article

Postoperative complications after closure of a diverting ileostoma—differences according to closure technique

Original Article

Downregulation of Notch-1/Jagged-2 in human colon tissues from Hirschsprung disease patients

Letter to the Editor

Blood albumin level in cases with colorectal cancer

Review

Botulinum toxin and anal fissure: Efficacy and safety systematic review

Neu im Fachgebiet Chirurgie

23.04.2024 | Ablationstherapie | Nachrichten

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 | Appendizitis | Nachrichten

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 | Operationsvorbereitung | Nachrichten

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

19.04.2024 | EAU 2024 | Kongressbericht | Nachrichten

Ureterstriktur: Innovative OP-Technik bewährt sich
weitere anzeigen

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.